On page 391, after line 28, insert the following:

"(72) $5,000 of the general fund—state appropriation for fiscal year 2026 and $5,000 of the general fund—state appropriation for fiscal year 2027 are provided solely for the University of Washington to conduct a prospective, randomized cohort study between July 1, 2025, and June 30, 2027, to determine the extent to which ibogaine-assisted therapy conducted through a licensed clinic in North America followed by structured therapeutic support presents advantages over treatment as usual for adults diagnosed with opioid use disorder compared to the current standard United States interventions of medication-assisted treatment and psychotherapy. The study must measure outcomes including, but not limited to, treatment engagement, reduction in opioid use, mortality, functional status, craving, motivation to change, and self-efficacy, using toxicology, standard scales, and other credible research techniques. The university may obtain and utilize private philanthropic funding to assist with the study required by this subsection."

EFFECT: Provides funding for the University of Washington (UW) to conduct a study to determine the extent to which ibogaine-assisted therapy conducted through a licensed clinic in North America, followed by structured therapeutic support, presents advantages over treatment as usual for adults diagnosed with opioid use disorder compared to the current standard interventions of medication-assisted treatment and psychotherapy. Allows UW to obtain and utilize private philanthropic funding to assist with the study.